Banco Macro S.A.
NYSE:BMABanks - Regional
+$1.53 today
- Market cap
- $3.45B
- Beta
- 0.50
- P/E (TTM)
- 25.5
- EPS (TTM)
- $579.33
- Dividend yield
- 4.63%
Volume 0.27M
Average 0.32M
BMA Financing Cash Flow
Net cash exchanged with lenders and shareholders through borrowing, repayments, buybacks, and dividends.
Banco Macro S.A.NYSE: BMA
Financing Cash Flow · Q2 FY2026 · quarter ended Jun 2026
Financing cash flow turns negative
Q2 FY2026 financing cash flow was -ARS 263.38B, compared with ARS 921.87B a year earlier. Trailing-twelve-month financing cash flow was -ARS 101.98B. Over 3 fiscal years it compounded at -75.0% a year.
Context
- Financing cash flow amounted to 0.0% of revenue in FY2025, down 7.6 pp from a year earlier.
- Financing cash flow increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly financing cash flow holds near -ARS 263.38B or moves back toward the trailing-twelve-month quarterly average of -ARS 25.5B.
Sources:Cash FlowText generated from reported figures; not investment advice.
Financing Cash Flow history
ARS · from the cash flow
- Latest · FY2025
- 2.41B ARS
- Year-over-year change
- -99.5%
| Period | Period end | Financing Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.41B | -99.5% |
| FY2024 | 2024-12-31 | 491.52B | +116.9% |
| FY2023 | 2023-12-31 | (2.9T) | -1975.3% |
| FY2022 | 2022-12-31 | 154.79B | +150.4% |
| FY2021 | 2021-12-31 | (306.88B) | — |
Financing Cash Flow vs competitors
How BMA compares with its peers on the latest reported figures
- Peers report in different currencies, so financing cash flow is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -109.0% is the lowest of 8, against a peer median of +127.8%.
- Financing cash flow amounts to 2.1% of revenue for BMA, versus a peer median of 34.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | COP 30.05T COP | +127.8% | +41.2% | 71.1% | |
| LTM Jun 2026 | ARS 101.98B ARS | -109.0% | -75.0% | 2.1% | |
| LTM Jun 2026 | $4.24B USD | +556.8% | — | 118.9% | |
| LTM Jun 2026 | $2.96B USD | +354.7% | -29.2% | 99.3% | |
| LTM Jun 2026 | $764M USD | -49.2% | +292.0% | 28.2% | |
| LTM Jun 2026 | $486.91M USD | +6.8% | -58.0% | 34.8% | |
| LTM Jun 2026 | $401.52M USD | +541.4% | +83.5% | 22.3% | |
| LTM Jun 2026 | $196.11M USD | -88.7% | +32.4% | 11.0% | |
| Peer median (excluding BMA) | — | +127.8% | +36.8% | 34.8% | |
Competitors are the stored peer set for BMA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 145.94B | 24.04B | 972.16M | 129.16B | 289.42B |
| Depreciation & Amortization | 43.22B | 103.41B | 64.92M | 138.14B | 0 |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 |
| Change in Working Capital | 34.07B | 442.03B | (1.94T) | (4.79T) | 566.51B |
| Accounts Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital | 34.07B | 442.03B | (1.94T) | (4.79T) | 566.51B |
| Other Non-Cash Items | (96.95B) | 32.29B | 1.69T | 5.45T | 1.61T |
| Operating Cash Flow | 271.77B | 1.61T | (85.23B) | 918.59B | 1.7B |
| Capital Expenditures | (41.81B) | (75.75B) | (57.07B) | (124.52B) | (138.06M) |
| Acquisitions (Net) | (216.27M) | 0 | (24.54M) | (8.53B) | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 9.19B | 0 | 0 |
| Other Investing Activities | 0 | (89.24B) | 280.87B | (42.82B) | (3.24B) |
| Investing Cash Flow | (42.03B) | (164.99B) | 232.96B | (175.87B) | (3.38B) |
| Debt Repayment | (8.92B) | (6.36B) | 4.06B | (116.74B) | 795.76B |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | (210.85M) |
| Dividends Paid | 0 | (59.46B) | (179.68M) | (466.94B) | (315.04B) |
| Other Financing Activities | (297.96B) | 220.62B | (2.91T) | 1.08T | (478.1B) |
| Financing Cash Flow | (306.88B) | 154.79B | (2.9T) | 491.52B | 2.41B |
| Effect of Forex Changes | 52.77B | 393.37B | 1.98T | (1.44T) | (736.58M) |
| Net Change in Cash | (171.34B) | 1.73T | (950.85B) | (199.12B) | (2.86T) |
| Free Cash Flow | 229.96B | 1.54T | (142.3B) | 794.07B | 1.56B |
Banco Macro S.A.
NYSE:BMA
Intrinsic Alpha fair value
Locked
Current Price
$53.91
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.